Literature DB >> 11797101

Dog MHC alleles containing the human RA shared epitope confer susceptibility to canine rheumatoid arthritis.

W E Ollier1, L J Kennedy, W Thomson, A N Barnes, S C Bell, D Bennett, J M Angles, J F Innes, S D Carter.   

Abstract

To determine whether canine rheumatoid arthritis (CRA) is associated with dog MHC (DLA-DRB1) alleles which contain the QRRAA/RKRAA conserved third hypervariable region (3HVR) sequence, DNA samples were extracted from 61 dogs with clinically diagnosed small-joint polyarthritis and from 425 controls. Breed-matched controls were available for 41 cases. DLA-DRB1 genotypes were identified using molecular typing methods. Phenotype frequencies were compared between cases and controls and odds ratios with 95% confidence intervals calculated. Several DLA-DRB1 alleles were associated with increased risk for CRA: DLA-DRB1*002, DRB1*009, and DRB1*018. This was also observed for the presence of any shared epitope (SE)-bearing allele. The associations with DLA-DRB1*002 and the SE were maintained when only breed-matched cases and controls were compared. This study suggests that a conserved amino acid motif in the 3HVR present in some DRB1 alleles of both dogs and humans is associated with rheumatoid arthritis in both species.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11797101     DOI: 10.1007/s002510100372

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  23 in total

Review 1.  The quest for better understanding of HLA-disease association: scenes from a road less travelled by.

Authors:  Joseph Holoshitz
Journal:  Discov Med       Date:  2013-09       Impact factor: 2.970

Review 2.  New insights into the functional role of the rheumatoid arthritis shared epitope.

Authors:  Denise E de Almeida; Song Ling; Joseph Holoshitz
Journal:  FEBS Lett       Date:  2011-03-22       Impact factor: 4.124

3.  A temporal analysis shows major histocompatibility complex loci in the Scandinavian wolf population are consistent with neutral evolution.

Authors:  J M Seddon; H Ellegren
Journal:  Proc Biol Sci       Date:  2004-11-07       Impact factor: 5.349

4.  MHC molecules in health and disease: At the cusp of a paradigm shift.

Authors:  Denise E de Almeida; Joseph Holoshitz
Journal:  Self Nonself       Date:  2011-01-01

5.  Clinical features and pathological joint changes in dogs with erosive immune-mediated polyarthritis: 13 cases (2004-2012).

Authors:  Magen L Shaughnessy; Susannah J Sample; Carter Abicht; Caitlin Heaton; Peter Muir
Journal:  J Am Vet Med Assoc       Date:  2016-11-15       Impact factor: 1.936

6.  Expanded dog leukocyte antigen (DLA) single nucleotide polymorphism (SNP) genotyping reveals spurious class II associations.

Authors:  N Safra; N C Pedersen; Z Wolf; E G Johnson; H W Liu; A M Hughes; A Young; D L Bannasch
Journal:  Vet J       Date:  2011-07-07       Impact factor: 2.688

Review 7.  Association of susceptible genetic markers and autoantibodies in rheumatoid arthritis.

Authors:  Vasanth Konda Mohan; Nalini Ganesan; Rajasekhar Gopalakrishnan
Journal:  J Genet       Date:  2014-08       Impact factor: 1.166

8.  Variants in the interleukin-1 alpha and beta genes, and the risk for periodontal disease in dogs.

Authors:  C Albuquerque; F Morinha; J Magalhães; J Requicha; I Dias; H Guedes-Pinto; E Bastos; C Viegas
Journal:  J Genet       Date:  2015-12       Impact factor: 1.166

9.  Alleles of the major histocompatibility complex play a role in the pathogenesis of pancreatic acinar atrophy in dogs.

Authors:  Kate L Tsai; Alison N Starr-Moss; Gopalakrishnan M Venkataraman; Christopher Robinson; Lorna J Kennedy; Jörg M Steiner; Leigh Anne Clark
Journal:  Immunogenetics       Date:  2013-04-21       Impact factor: 2.846

10.  MHC class II polymorphism is associated with a canine SLE-related disease complex.

Authors:  Maria Wilbe; Päivi Jokinen; Christina Hermanrud; Lorna J Kennedy; Erling Strandberg; Helene Hansson-Hamlin; Hannes Lohi; Göran Andersson
Journal:  Immunogenetics       Date:  2009-07-28       Impact factor: 2.846

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.